Microba Life Sciences Limited (ASX:MAP)

Australia · Delayed Price · Currency is AUD

0.0860

+0.0010 (1.18%)

Feb 26, 2026, 4:10 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
Testing Services and Supplements	15.67M	12.09M	5.42M	4.69M	3.73M
Testing Services and Supplements Growth	29.60%	123.06%	15.60%	25.62%	-
Total	15.67M	12.09M	5.42M	4.69M	3.73M
Total Growth	29.60%	123.06%	15.60%	25.62%	28.31%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
Australia	5.41M	4.20M	3.16M	2.62M	2.01M
Australia Growth	28.62%	32.98%	20.59%	30.36%	-30.87%
Europe	1.37M	1.77M	1.08M	774.73K	413.79K
Europe Growth	-22.42%	63.67%	39.69%	87.23%	-
New Zealand	6.93K	127.03K	163.57K	259.47K	252.69K
New Zealand Growth	-94.54%	-22.34%	-36.96%	2.68%	-
United Arab Emirates	97.52K	662.34K	456.71K	266.65K	-
United Arab Emirates Growth	-85.28%	45.03%	71.27%	-	-
United Kingdom	7.54M	4.53M	1.24K	691.00	83.62K
United Kingdom Growth	66.43%	366514.48%	78.87%	-99.17%	-
United States	942.52K	602.86K	554.46K	765.37K	971.22K
United States Growth	56.34%	8.73%	-27.56%	-21.19%	-
Asia	13.74K	22.05K	407.00	-	-
Asia Growth	-37.67%	5317.69%	-	-	-
Ireland	285.02K	168.85K	-	-	-
Ireland Growth	68.80%	-	-	-	-
Total	15.67M	12.09M	5.42M	4.69M	3.73M
Total Growth	29.60%	123.06%	15.60%	25.62%	28.31%

Source: S&P Global Market Intelligence.